Procter & Gamble (NYSE:PG) is a leading consumer goods company known for its diverse range of products, including household care, beauty, and health care items. As PG prepares to release its quarterly earnings on October 24, 2025, Wall Street analysts have set expectations for an earnings per share (EPS) of $1.90 and projected revenue of approximately $22.17 billion.
P&G's focus on innovation and cost-saving measures has been instrumental in driving steady organic growth. Despite challenges like inflation and market pressures in Greater China, the company has managed to maintain consistent organic sales growth. The fiscal Q1 model projects a 1.9% increase in organic sales, with significant contributions from the Health Care and Grooming segments.
However, higher commodity costs and tariffs may have impacted P&G's margins. The Zacks Consensus Estimate for fiscal first-quarter revenues is $22.15 billion, reflecting a 1.9% increase from the previous year. The earnings estimate of $1.90 per share represents a 1.6% decline from the same quarter last year, with the consensus remaining unchanged over the past 30 days.
P&G has been trailing behind the S&P 500 and its staple peers, but there is potential for recovery. The company is actively reducing costs and revamping its cost base, which could position it well for future performance. Despite the anticipated decline in earnings, P&G is expected to achieve above-average market growth.
The upcoming earnings report could significantly influence PG's stock performance. A positive earnings surprise might lead to a rise in the stock price, while a miss could result in a decline. The management's discussion during the earnings call will be crucial in assessing the sustainability of any immediate price changes and future earnings expectations.
